BioSpace News Archive

Deals

CVS and Aetna Cleared for Merger as Companies Tighten Leadership Roles

The U.S. Department of Justice has given preliminary approval for CVS’ $69 billion acquisition of Aetna after Aetna divested its Medicare Part D business.

October 11, 2018
·
3 min read
·
Alex Keown
Drug Development

October 12 Research Roundup: Alzheimer’s, CRISPR, Breast Cancer and Global Warming

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

October 11, 2018
·
7 min read
·
Mark Terry
How to Reach Your Goals at Work Despite Negative Nancy

“That can never be done.” “We’ve tried that already.” “Those plans always fail around here.” “We’re smart, and have already thought of everything.” Those are just a few of the statements you might hear from a “Negative Nancy” at work

October 11, 2018
·
3 min read
·
Porschia Parker
Business

A Look Inside New MS Data With Biogen’s Medical Director of Clinical Development

There is a lot of anticipated excitement for multiple sclerosis treatments unveiled by Biogen at the 34th Congress of the European Committee for Treatment and Research in MS in Berlin.

October 11, 2018
·
3 min read
·
Alex Keown
Business

Chinese Pharma Companies Continue to Shake Hands With Western Partners

Brii Biosciences is one of many China-based companies that are heavily investing in U.S. biotech and pharmaceutical companies to support the development of programs that could come back to China for approval.

October 11, 2018
·
3 min read
·
Alex Keown